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Progress in Cancer Research and
Therapy, Vol. 5-Cancer Invasion and
Metastasis: Biological Mechanisms
and Therapy. Eds. S. B. DAY, W. P.
LAIRD MYERS, P. STANSLY, S. GARATTINI,
M. G. LEWIS. (1977) New York: Raven
Press. 540 pp. U.S. $42.00 net.
This book represents the proceedings of an
international disciplinary workshop spon-
sored by the Sloan Kettering Memorial
Cancer Centre, the NCI Bethesda and Mario
Negri Institute for Pharmacological Research
in Milan, that took place in December, 1976.
The book is divided into sections which
look at basic factors in cellular invasion, the
process of metastatic spread, the establish-
ment and distribution ofmetastasis, immuno-
logical aspects and tumour immunity, and,
finally, the treatment and prevention of
metastatic disease. It is perhaps unfortunate
that none of the meeting's discussion is
included in the text, although for some
sections there is a summary of the discussion
by one or other of the participants. Many of
the proffered papers, in fact, were reviews
of published work but some data from newer
model systems either in vitro or in vivo were
also presented.
Overall, this collection of papers represents
a good cross-section of work presently in
progress in the field of metastasis, both
experimentally and clinically.
The introductory chapter "On the Nature
of Metastasis" is neither authoritative nor
constructive in the context of these proceed-
ings. It is unfortunate that Dr. Day included
his own introduction in these proceedings,
because it appears to have been based on
semantic and quasi-philosophical ideas which
in no way set the scene for the ensuing
scientific presentations.
These small criticisms apart, this book can
berecommended forallscientistsandclinicians
interested in metastasis as a phenomenon of
malignancy.
H. BUSH
Recent Advances in Cancer Treatment,
Vol. 3. Eds. H. J. TAGNON and M. J.
STAQUET. (1977) New York: Raveni Press,
EORTC. 360 pp. U.S. $26.00 net.
This volume is based on a symposium held
in Brussels in September 1976 in honour of
Henri J. Tagnon. Its extensive international
cast dealt with individual tumour topics,
some from the point of view of chemotherapy
alone, others from the point of view of
general clinical management, and whilst it
makes no claims to comprehensiveness, the
papers deal with some of the most pressing
current problems. In addition, there are a
number of review papers dealing with cancer
therapy in a more general sense, with discus-
sion of some of the more controversial issues.
The arrangement of the papers does not
appear to have followed any specific pattern
but there is much here of interest. It is a
book to be dipped into to obtain individual
workers' specific viewpoints on important
topics rather than a broad review of the
current scene.
K. D. BAGSHAWE
Evans' Histological Appearances of
Tumours, 3rd Edition D. J. B. ASHLEY.
(1978) Edinburgh: Churchill Livingstone
857 pp. £40.00 net.
Dr. Winston Evans' well-known "Histo-
logical Appearances of Tumours" first ap-
peared in 1956. It was immediately recognised
as an indispensable bench book for the
practising and trainee histopathologist, and
it has maintained that position ever since. A
second edition appeared in 1966, but following
Dr. Winston Evans' untimely death one had
sadly assumed that no further edition would
appear. It was therefore welcome news that
Dr. Ashley had undertaken a third edition-
if for no better reason than the impending
disintegration, from constant use, of one's
copy of the second.
It is no easy task to update the work of
another author, particularly where the book
reflects the original author's individual ap-
proach as strongly as this book. This was
always more than an atlas of tumour histo-
pathology-Winston Evans was no mere
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with the biological behaviour and clinical
effects of tumours as well as the diagnostic
features of their cell structure.
Dr. Ashley has wisely left the main
structure of the book intact. The text and
the valuable bibliographies have been ex-
panded to take account of recent work, and
some new illustrations added. The chapters
have been slightly rearranged, the chapter
on lymphoid tumours extensively revised,
and a section on teratomas added. Dr. Ashley
has added a brief introductory essay to each
ofthe 8 sections into which the book had been
divided. But, substantially, this is Winston
Evans' text, and his microphotographs.
This is not apparent at first sight. This
edition looks very different from the first
two. The whole text has been re-set in double
columns on a larger page, and this has
reduced the pages from 1250 to 850 or so. A
smaller and less easily legible typeface has
been used. A wNhiter and glossier paper, how-
ever, improves the look of the illustrations,
though a few of these have lost some of their
crispness, and some have been reduced in
size (not magnification). An odd feature of
the layout is that the illustrations actuallv
look smaller, even when they are not.
Dr. Ashley writes in his preface: "I have
followed Dr. Evans in aiming to produce a
wTork which will be helpful to the practising
histopathlologist and to his clinical colleagues
in their daily work as wtell as to the trainee
andtotheresearch worker." Hehassucceeded,
and deserves congratulations and thanks for
giving a new lease of life to this classic text.
The one feature that has changed drastic-
ally since the last edition is the price. But,
even at £40. this is an indispensable book for
the hospital pathology department and the
cancer research laboratory.
0. G. DODGE
Progesterone Receptors in Normal and
Neoplastic Tissues-Progress in Can-
cer Research and Therapy, Vol. 4. Eds.
W. L. MCGUIRE, J.-P. RAYNAUD, E. E.
BAULIEU. (1977) New York: Raven Press.
345 pp. U.S. $30.00 net.
A previous volume, "Estrogen Receptors
in Human Breast Cancer", issued in 1975 by
the same publishers, rapidly established itself
as the authoritative revie-w of the status of
the oestrogen-receptor (ER) assay as a pre-
dictor of the probable resuilts of endocrine
therapy in treatment of malignant breast
disease. It was recognized at that time that
the presence of ER in a tumour appeared to
be a necessary but not sufficient condition
for hormone dependence. The problem re-
mained that some 4000 of patients with
positive tumour ER failed to respond to
endocrine therapy, emphasising the need for
additional markers of hormone dependency,
more distal to the initial binding step (ER).
Horwitz and McGuire proposed that the
presence of progesterone receptor (PgR),
whose synthesis (in e.g. uterus) was known
to be oestrogen dependent and which could
be considered as a biological end-product of
an intact hormone regulating system, would
serve as an additional, more accurate, pre-
dictor of "hormone dependence" in breast
cancer.
The clinician anticipating that this book
would be a direct sequel to the previous
volume, establishing the credentials of PgR
as a predictor of tumour hormone response in
the same way that the earlier book did for
ER, is liable to suffer disappointment. Good
reliable data relating PgR incidence to
response to endocrine therapy is still very
scarce, one of the main reasons being the
unsuitability of radioactive progesterone as
a ligand for measuring PgR in many species,
including man. With the advent of the
Roussel-Uclaf synthetic progestin R5020 it
became possible at last to measure PgR un-
equivocally. R5020 has a high affinity for
progestin receptor, with which it forms a
much more stable complex than progesterone
itself; it does not bind to plasma transcortin
(CBG). These attributes, coupled with neglig-
ible interference with other steroid receptors,
have led to rapid advances in the detection,
characterization and assay of PgR in target
and tumour tissue.
This book might well be sub-titled: "The
properties and uses ofR5020". Unfortunately
little or no mention is made ofother synthetic
progestins such as Organon 2058 (claimed to
be more specific than R5020) which might
equally w^ell be deployed in the PgR assay.
The book presents papers from 20 different
teams of leading investigators in the receptor
field who met in the autumn of 1976 at a
Workshop sponsored by Roussel (Canada)
Ltd. in Montebello, Quebec. Contributions
came from teams in U.S.A., Canada, France,
Belgium, Holland, Germany, Sweden, Den-
mark and Israel, but none, significantly,